Is CFAP92 p.Arg206Gln (c.617G>A) pathogenic?

CFAP92 p.Arg206Gln (c.617G>A) is classified Uncertain significance in CFAP92 (ClinVar, Single submitter, 1 submitter; last evaluated 2023-09-13). AlphaMissense: likely benign (0.2484); Very rare (popmax 0.00446%, eas).

How common is CFAP92 p.Arg206Gln (c.617G>A) in the general population?

CFAP92 p.Arg206Gln (c.617G>A) is very rare (popmax 0.00446%, eas) (gnomAD).

What do computational predictors say about CFAP92 p.Arg206Gln (c.617G>A)?

AlphaMissense predicts likely benign (score 0.2484) — an in-silico prediction, not a clinical call.

CFAP92 p.Arg206Gln

c.617G>A · rs1360080632 · VCV2623237

Uncertain significance Single submitter

Classification

Uncertain significance

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely benign

0.2484 · ACMG-weighted

gnomAD v4.1

Rare

very rare (popmax 0.00446%, eas)

Missense predictors

0/3 damaging

AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense	0.2484	likely benign
REVEL	0.039	moderately benign-leaning
SaProt	LLR -7.22	tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -0.058	GERP 0.39
Regional constraint	o/e 0.94	unconstrained · MANE · 83 kb · p 0.026 · regional, not allelic
Overall
CADD	16.1	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.00446% East Asian · 2/44,888 alleles

Filtering AF 0.000739% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000276%

Overall 0.000753% 11/1,461,706 alleles · very rare

Ancestry group	Frequency	1 in
East Asiangrpmax	0.00446%	22,444
South Asian	0.0022%	45,541
Admixed American	0.00167%	60,020
Finnishnot grpmax-eligible	0.00156%	64,006
European (non-Finnish)	0.000424%	235,978

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: CFAP92
Protein: p.Arg206Gln
Coding: c.617G>A
MANE Select: NM_001394090
dbSNP: rs1360080632
Type: single nucleotide variant
Location: chr3:128987666 (GRCh38)
Gene constraint: LOEUF 0.959 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 57.39

Full CFAP92 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

ACAD9 c.1692+1G>A Likely pathogenic ★★ same type
ACAD9 p.Arg532Gln Likely pathogenic ★★ ⚠ same type
ACAD9 p.Asn569His Uncertain significance ★★ ⚠ same type
ACAD9 p.Glu596Lys Uncertain significance ★★ ⚠ same type
ACAD9 c.1692+145G>C Benign ★★ same type
ACAD9 c.*26C>T Benign/Likely benign ★★ same type
ACAD9 c.*331T>G Benign/Likely benign ★★ same type
ACAD9 c.*68C>T Benign/Likely benign ★★ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cfap92-p-arg206gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown